Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sanjeev Narula currently holds 214,718 shares of Intra-Cellular Therapies, Inc. (ITCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sanjeev Narula has been a net neutral trader of ITCI stock. They have purchased $0 and sold $0 worth of shares.
Sanjeev Narula's most recent insider trade was on Oct 6, 2026, when they sold 13,485 shares at $6.78 per share.
Sanjeev Narula serves as Executive at Intra-Cellular Therapies, Inc. (ITCI). They have executed 22 insider transactions totaling $0 over their tenure at the company.
Sanjeev Narula holds the position of Executive at Intra-Cellular Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Sanjeev Narula has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Sanjeev Narula was on Mar 4, 2023, when they sold $188.2K worth of VTRS shares. This transaction involved 16,909 shares at $11.13 per share.
Sanjeev Narula currently owns 214,718 shares of Intra-Cellular Therapies, Inc. (ITCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sanjeev Narula's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sanjeev Narula has 22 Form 4 filings on record as an insider at Intra-Cellular Therapies, Inc..
Set alerts for Sanjeev Narula and 40,000+ other insiders.